Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01602536 · ClinicalTrials.gov registry record · NA
Twitter-enabled Mobile Messaging for Smoking Relapse Prevention
A NA study, sponsored by University of California, Irvine.
- Completed
- Registry status
- NA
- Development phase
- 160
- Enrollment target
NCT01602536 is a NA study that has completed, run by University of California, Irvine. The registered enrollment target is 160 participants.
The verdict
NCT01602536, a NA study, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
Study Summary
We conducted a two-arm (test vs. control, N=160) randomized controlled trial of small, private, online support groups for quitting smoking with 20 people per group who were seeking to quit smoking. A novel feature was a bot (auto-messenger) that posted a daily cessation-related discussion topic in each group, timed to the group's quit date.
Interventions
- BEHAVIORAL smoking cessation aides
- BEHAVIORAL Twitter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2012-01 |
| Est. Completion | 2014-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01602536
The ClinicalTrials.gov registry entry for NCT01602536 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which smoking cessation aides is the first listed.
NCT01602536 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01602536 about?
NCT01602536 is a clinical study titled "Twitter-enabled Mobile Messaging for Smoking Relapse Prevention". We conducted a two-arm (test vs. control, N=160) randomized controlled trial of small, private, online support groups for quitting smoking with 20 people per group who were seeking to quit smoking. A novel feature was a bot (auto-messenger) that posted a daily cessation-related discussion topic in e...
What is the current status of trial NCT01602536?
This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2012-01. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01602536?
The interventions under investigation include: smoking cessation aides (BEHAVIORAL), Twitter (BEHAVIORAL).
Who is sponsoring clinical trial NCT01602536?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.